|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
GB1405088A
(en)
|
1971-06-03 |
1975-09-03 |
Mundipharma Ag |
Slow release formulation
|
|
US3965256A
(en)
|
1972-05-16 |
1976-06-22 |
Synergistics |
Slow release pharmaceutical compositions
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
GB1478759A
(en)
|
1974-11-18 |
1977-07-06 |
Alza Corp |
Process for forming outlet passageways in pills using a laser
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4063064A
(en)
|
1976-02-23 |
1977-12-13 |
Coherent Radiation |
Apparatus for tracking moving workpiece by a laser beam
|
|
US4285987A
(en)
|
1978-10-23 |
1981-08-25 |
Alza Corporation |
Process for manufacturing device with dispersion zone
|
|
US4200098A
(en)
|
1978-10-23 |
1980-04-29 |
Alza Corporation |
Osmotic system with distribution zone for dispensing beneficial agent
|
|
US4466968A
(en)
*
|
1980-11-24 |
1984-08-21 |
Dermall, Ltd. |
Method for prophylaxis or treatment of emesis and nausea
|
|
US4416886A
(en)
*
|
1981-07-29 |
1983-11-22 |
Dermall Limited |
Method of treating pruritis and composition therefor
|
|
US4987136A
(en)
|
1982-03-16 |
1991-01-22 |
The Rockefeller University |
Method for controlling gastrointestinal dysmotility
|
|
US4443428A
(en)
|
1982-06-21 |
1984-04-17 |
Euroceltique, S.A. |
Extended action controlled release compositions
|
|
US4588580B2
(en)
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
ES2058111T3
(es)
|
1986-06-10 |
1994-11-01 |
Euro Celtique Sa |
Composicion de liberacion controlada de dihidrocodeina.
|
|
US4785000A
(en)
|
1986-06-18 |
1988-11-15 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
|
US4769372A
(en)
|
1986-06-18 |
1988-09-06 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
|
US4970075A
(en)
|
1986-07-18 |
1990-11-13 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
|
US4861598A
(en)
|
1986-07-18 |
1989-08-29 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
|
GB8626098D0
(en)
|
1986-10-31 |
1986-12-03 |
Euro Celtique Sa |
Controlled release hydromorphone composition
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5698155A
(en)
|
1991-05-31 |
1997-12-16 |
Gs Technologies, Inc. |
Method for the manufacture of pharmaceutical cellulose capsules
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5656295A
(en)
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5286493A
(en)
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5273760A
(en)
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
US5472712A
(en)
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
|
US5985880A
(en)
*
|
1996-06-05 |
1999-11-16 |
Delta Pharmaceuticals |
Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
|
|
US5324351A
(en)
|
1992-08-13 |
1994-06-28 |
Euroceltique |
Aqueous dispersions of zein and preparation thereof
|
|
US5512578A
(en)
*
|
1992-09-21 |
1996-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
|
US5500227A
(en)
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
US6210714B1
(en)
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
|
US5891471A
(en)
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
|
US5843480A
(en)
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5914131A
(en)
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
US6881208B1
(en)
|
1995-06-05 |
2005-04-19 |
Joseph B. Phipps |
Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
|
|
FR2738741B1
(fr)
*
|
1995-09-19 |
1997-12-05 |
Oreal |
Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
|
|
WO1997045091A2
(en)
|
1996-05-31 |
1997-12-04 |
Euro-Celtique, S.A. |
Sustained release oxycodone formulations with no fed/fast effect
|
|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
WO1999016642A1
(en)
|
1997-09-26 |
1999-04-08 |
Magna Interior Systems Inc. |
Fastener assembly for joining two interior panels
|
|
US6559158B1
(en)
|
1997-11-03 |
2003-05-06 |
Ur Labs, Inc. |
Use of methylnaltrexone and related compounds to treat chronic opioid use side affects
|
|
TR200001942T2
(tr)
|
1997-12-22 |
2000-11-21 |
Euro-Celtique, S.A. |
Opioid agonist/antagonist kombinasyonlar
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
CN1204890C
(zh)
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
|
IL145508A0
(en)
|
1999-03-26 |
2002-06-30 |
Euro Celtique Sa |
Aryl substituted pyrazole, imidazole, oxazole, thiazole and pyrrole derivatives and pharmaceutical compositions containing the same
|
|
CA2382577C
(en)
|
1999-08-27 |
2008-01-22 |
Southern Research Institute |
Injectable buprenorphine microparticle compositions and their use
|
|
EP2295043A1
(en)
|
1999-10-29 |
2011-03-16 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
|
SI2283842T1
(sl)
|
2000-02-08 |
2015-07-31 |
Euro-Celtique S.A. |
Oralne formulacije opioidnih agonistov, varne pred zlorabo
|
|
AU2002227383B2
(en)
|
2000-10-30 |
2004-07-08 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
JP2005500258A
(ja)
*
|
2001-03-23 |
2005-01-06 |
アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ |
Gm1ガングリオシドを阻害することによる、鎮痛効力を増大し、そして、ニ峰作用性オピオイドアゴニストの有害な興奮性効果を減弱する方法。
|
|
EP1387673B1
(en)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Abuse-resistant controlled-release opioid dosage form
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US7157103B2
(en)
|
2001-08-06 |
2007-01-02 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing irritant
|
|
US7141250B2
(en)
|
2001-08-06 |
2006-11-28 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing bittering agent
|
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
|
US7144587B2
(en)
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
DE10147501A1
(de)
|
2001-09-26 |
2003-04-10 |
Wella Ag |
Perlglänzende Haarkur
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
LT2425821T
(lt)
|
2002-04-05 |
2017-07-25 |
Euro-Celtique S.A. |
Farmacinis preparatas, turintis oksikodono ir naloksono
|
|
PT2561860T
(pt)
|
2002-05-31 |
2018-05-08 |
Titan Pharmaceuticals Inc |
Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
|
|
AU2003297074A1
(en)
*
|
2002-12-13 |
2004-07-09 |
Euro-Celtique S.A. |
Transdermal buprenorphine to treat pain in sickle cell crisis
|
|
MXPA05013295A
(es)
*
|
2003-06-10 |
2006-03-09 |
Janssen Pharmaceutica Nv |
Derivado sustituido de 1,4-piperidin-4-il-piperazina combinado con un analgesico opioideo y su uso para el tratamiento de dolor y efectos secundarios asociados con tratamientos de base opioidea.
|
|
DE602004009449T2
(de)
*
|
2003-07-25 |
2008-07-24 |
Euro-Celtique S.A. |
Behandlung von entzug
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
TWI365880B
(en)
|
2004-03-30 |
2012-06-11 |
Euro Celtique Sa |
Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
|
|
PL1768650T3
(pl)
|
2004-06-04 |
2009-01-30 |
Camurus Ab |
Ciekłe formulacje depot
|
|
DE102005007859A1
(de)
|
2005-02-21 |
2006-08-24 |
Lts Lohmann Therapie-Systeme Ag |
Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen
|
|
EP1695700A1
(en)
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
|
US20060281775A1
(en)
|
2005-06-14 |
2006-12-14 |
Applied Pharmacy Services, Inc. |
Two-component pharmaceutical composition for the treatment of pain
|
|
WO2007005716A2
(en)
|
2005-06-30 |
2007-01-11 |
Cinergen, Llc |
Methods of treatment and compositions for use thereof
|
|
WO2007013975A2
(en)
|
2005-07-20 |
2007-02-01 |
Pharmorx Inc. |
Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications
|
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
|
EP2040698A4
(en)
*
|
2006-07-14 |
2011-08-10 |
Shionogi & Co |
OXIM CONNECTIONS AND ITS USE
|
|
ES2577390T3
(es)
|
2006-07-21 |
2016-07-14 |
Biodelivery Sciences International, Inc. |
Dispositivos de administración transmucosa con mayor captación
|
|
ES2549115T3
(es)
|
2006-09-22 |
2015-10-23 |
Zynerba Pharmaceuticals, Inc. |
Profármacos de buprenorfina administrables por vía transdérmica y composiciones resistentes al consumo excesivo de los mismos
|
|
US8653066B2
(en)
|
2006-10-09 |
2014-02-18 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
|
EP2089010A1
(en)
|
2006-10-24 |
2009-08-19 |
The John Hopkins University |
Rapid release mini-tablets provide analgesia in laboratory animals
|
|
JP2010509227A
(ja)
*
|
2006-11-07 |
2010-03-25 |
ネクター セラピューティックス エイエル,コーポレイション |
オピオイド作動薬およびオピオイド拮抗薬の用量形態および同時投与
|
|
US20080199407A1
(en)
*
|
2007-02-15 |
2008-08-21 |
Slater Kenneth C |
Drug Detoxification Protocol Using Microdosing
|
|
GB2447013A
(en)
|
2007-03-01 |
2008-09-03 |
Reckitt Benckiser Healthcare |
Analgesic composition containing buprenorphone and nalmefene
|
|
DE102007021549A1
(de)
*
|
2007-05-08 |
2008-11-13 |
Novosis Ag |
Transdermales therapeutisches System enthaltend mindestens zwei Opioide
|
|
EP2240022B1
(en)
|
2008-01-09 |
2016-12-28 |
Charleston Laboratories, Inc. |
Bilayered tablets comprising oxycodone and promethazine
|
|
EP2262367A4
(en)
|
2008-03-08 |
2011-04-20 |
Theraquest Biosciences Inc |
PHARMACEUTICAL ORAL COMPOSITIONS OF BUPRENORPHINE AND METHOD FOR THEIR USE
|
|
WO2009114648A1
(en)
|
2008-03-11 |
2009-09-17 |
Depomed Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
CA2718943A1
(en)
|
2008-03-26 |
2009-10-01 |
Alltranz Inc. |
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
|
|
TWI473614B
(zh)
|
2008-05-29 |
2015-02-21 |
Kyowa Hakko Kirin Co Ltd |
Anti-analgesic inhibitors
|
|
US8163731B2
(en)
|
2008-08-20 |
2012-04-24 |
Rhodes Technologies |
Method and dosage regimens for eliminating a chemical substance in blood
|
|
US20100227876A1
(en)
|
2009-03-06 |
2010-09-09 |
Rechfensen Llp |
Methods of Reducing Side Effects of Analgesics
|
|
WO2010141505A1
(en)
|
2009-06-01 |
2010-12-09 |
Protect Pharmaceutical Corporation |
Abuse-resistant delivery systems
|
|
US20110046173A1
(en)
|
2009-08-24 |
2011-02-24 |
Warren Charles Stern |
Combination analgesic opioid pain therapy
|
|
US8461171B2
(en)
|
2010-02-09 |
2013-06-11 |
QRxPharma Ltd. |
Hybrid opioid compounds and compositions
|
|
WO2011109743A2
(en)
|
2010-03-04 |
2011-09-09 |
Rand Jerry N |
Synergistic effects of combinations of buprenorphine and opioids for the treatment of pain
|
|
EP3064199B1
(en)
|
2010-04-02 |
2023-12-20 |
Buzzz Pharmaceuticals Limited |
Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
|
|
GB2481018B
(en)
|
2010-06-08 |
2015-03-18 |
Rb Pharmaceuticals Ltd |
Injectable flowable composition comprising buprenorphine
|
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
|
US8975270B2
(en)
|
2010-06-08 |
2015-03-10 |
Rb Pharmaceuticals Limited |
Injectable flowable composition comprising buprenorphine
|
|
DE102010048883A1
(de)
|
2010-10-19 |
2012-04-19 |
Lars Holger Hermann |
Verwendung von Buprenorphin zum Abususschutz von Opiat-Vollagonisten sowie entsprechende pharmazeutische Zusammensetzungen
|
|
PL2826467T3
(pl)
|
2010-12-22 |
2018-01-31 |
Purdue Pharma Lp |
Zamknięte, zabezpieczone przed manipulowaniem formy dozowania o kontrolowanym uwalnianiu
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
CN103547259A
(zh)
|
2011-03-25 |
2014-01-29 |
普渡制药公司 |
控制释放药物剂型
|
|
EP2714043A1
(en)
|
2011-05-31 |
2014-04-09 |
Qrxpharma Limited |
Compositions for sequential administration of opioid receptor agonists
|
|
PT2726064T
(pt)
|
2011-06-30 |
2016-12-28 |
Develco Pharma Schweiz Ag |
Forma de dosagem oral de libertação controlada compreendendo oxicodona
|
|
US9211293B2
(en)
|
2011-12-15 |
2015-12-15 |
Alkermes Pharma Ireland Limited |
Opioid agonist antagonist combinations
|
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
|
WO2013126552A1
(en)
|
2012-02-21 |
2013-08-29 |
Auburn University |
Buprenorphine nanoparticle composition and methods thereof
|
|
ES2716570T3
(es)
|
2012-04-17 |
2019-06-13 |
Purdue Pharma Lp |
Sistemas y procedimientos para tratar o prevenir una respuesta farmacodinámica adversa inducida por opioides
|
|
RU2012122945A
(ru)
|
2012-06-04 |
2013-12-10 |
Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации |
Аналгетическое средство
|
|
US9636308B2
(en)
|
2013-03-15 |
2017-05-02 |
Oakwood Laboratories LLC |
High drug load buprenorphine microspheres and method of producing same
|
|
TW201613590A
(en)
|
2014-09-12 |
2016-04-16 |
Purdue Pharma Lp |
Systems and methods for attenuating opioid-induced euphoria
|
|
US9849124B2
(en)
*
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|